Stay updated on BCG and ALT-803 Combo in Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page.

Latest updates to the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page
- Check3 days agoChange DetectedThe site revision label changed from v3.7.1 to v3.7.2. The clinical trial record information remains unchanged.SummaryDifference0.1%

- Check10 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedA new revision entry v3.7.0 is now shown in the study history, while the previous revision v3.6.6 is no longer listed in the current history view.SummaryDifference0.1%

- Check52 days agoChange DetectedA new revision entry v3.6.6 was added to the history, and the previous revision v3.6.5 was removed, reflecting an update to the version history for the study record.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page history now shows Revision: v3.6.5 replacing v3.6.4, indicating a new build of the interface or backend. This update does not appear to affect the study data or visible content.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 in the page footer, signaling a new site release. The update changes only the version label and does not modify the study record content or its history entries.SummaryDifference0.1%

Stay in the know with updates to BCG and ALT-803 Combo in Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCG and ALT-803 Combo in Bladder Cancer Clinical Trial page.